PART I Overview Novavax, Inc., together with our wholly owned subsidiaries, tackles some of the worlds most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M adjuvant and protein-based nanoparticles. Our corporate growth strategy focuses on maximizing the impact of our cutting-edge technology by forging partnerships for our Matrix-M adjuvant and research and development (R&D) assets while maintaining a lean and focused...
Q2 FY2026 — expected 2026-08-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001000694-26-000007 | EDGAR | 92K words |
| 2025-02-27 | 2024-12-31 | 0001000694-25-000004 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001000694-24-000007 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001000694-23-000005 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001000694-22-000004 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001000694-21-000004 | EDGAR | — |
| 2020-03-11 | 2019-12-31 | 0001104659-20-031944 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001144204-19-014640 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001144204-18-014686 | EDGAR | — |
| 2017-02-27 | 2016-12-31 | 0001144204-17-011334 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001000694-26-000018 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001000694-25-000046 | EDGAR | 32K words |
| 2025-08-06 | 2025-06-30 | 0001000694-25-000029 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001000694-25-000021 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001000694-24-000043 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001000694-24-000035 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001000694-24-000031 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001000694-23-000055 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001000694-23-000047 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001000694-23-000040 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001000694-22-000024 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001000694-22-000016 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001000694-26-000019 | EDGAR | — |
| 2026-02-26 | 0001000694-26-000011 | EDGAR | 5K words |
| 2026-01-20 | 0001104659-26-004785 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002725 | EDGAR | — |
| 2025-11-06 | 0001000694-25-000048 | EDGAR | — |
| 2025-11-04 | 0001104659-25-105818 | EDGAR | — |
| 2025-10-22 | 0001104659-25-101390 | EDGAR | — |
| 2025-10-07 | 0001104659-25-097317 | EDGAR | — |
| 2025-08-27 | 0001104659-25-084053 | EDGAR | — |
| 2025-08-27 | 0001104659-25-084049 | EDGAR | — |
317 total filings indexed. 285 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001000694 |
| Ticker | NVAX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.novavax.com |
| Listed | 1995-12-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NVAX (~200 tokens, structured JSON with cryptographic provenance)